Optogenetics in preclinical neuroscience and psychiatry research: recent insights and potential applications

Ross A McDevitt,1 Sean J Reed,2 Jonathan P Britt2,3 1Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD, USA; 2Integrated Program in Neuroscience, Montreal Neurological Institute, 3Department of Psychology, McGill University, Montreal, QC, C...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: McDevitt RA, Reed SJ, Britt JP
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2014
Materias:
Acceso en línea:https://doaj.org/article/b833782657eb403e816d3049381d267a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:b833782657eb403e816d3049381d267a
record_format dspace
spelling oai:doaj.org-article:b833782657eb403e816d3049381d267a2021-12-02T07:16:52ZOptogenetics in preclinical neuroscience and psychiatry research: recent insights and potential applications1178-2021https://doaj.org/article/b833782657eb403e816d3049381d267a2014-07-01T00:00:00Zhttp://www.dovepress.com/optogenetics-in-preclinical-neuroscience-and-psychiatry-research-recen-peer-reviewed-article-NDThttps://doaj.org/toc/1178-2021 Ross A McDevitt,1 Sean J Reed,2 Jonathan P Britt2,3 1Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD, USA; 2Integrated Program in Neuroscience, Montreal Neurological Institute, 3Department of Psychology, McGill University, Montreal, QC, Canada Abstract: There have been significant advances in the treatment of psychiatric disease in the last half century, but it is still unclear which neural circuits are ultimately responsible for specific disease states. Fortunately, technical limitations that have constrained this research have recently been mitigated by advances in research tools that facilitate circuit-based analyses. The most prominent of these tools is optogenetics, which refers to the use of genetically encoded, light-sensitive proteins that can be used to manipulate discrete neural circuits with temporal precision. Optogenetics has recently been used to examine the neural underpinnings of both psychiatric disease and symptom relief, and this research has rapidly identified novel therapeutic targets for what could be a new generation of rational drug development. As these and related methodologies for controlling neurons ultimately make their way into the clinic, circuit-based strategies for alleviating psychiatric symptoms could become a remarkably refined approach to disease treatment. Keywords: optogenetics, depression, anxiety, addiction, obsessive-compulsive disorderMcDevitt RAReed SJBritt JPDove Medical PressarticleNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol 2014, Iss default, Pp 1369-1379 (2014)
institution DOAJ
collection DOAJ
language EN
topic Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
spellingShingle Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
McDevitt RA
Reed SJ
Britt JP
Optogenetics in preclinical neuroscience and psychiatry research: recent insights and potential applications
description Ross A McDevitt,1 Sean J Reed,2 Jonathan P Britt2,3 1Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD, USA; 2Integrated Program in Neuroscience, Montreal Neurological Institute, 3Department of Psychology, McGill University, Montreal, QC, Canada Abstract: There have been significant advances in the treatment of psychiatric disease in the last half century, but it is still unclear which neural circuits are ultimately responsible for specific disease states. Fortunately, technical limitations that have constrained this research have recently been mitigated by advances in research tools that facilitate circuit-based analyses. The most prominent of these tools is optogenetics, which refers to the use of genetically encoded, light-sensitive proteins that can be used to manipulate discrete neural circuits with temporal precision. Optogenetics has recently been used to examine the neural underpinnings of both psychiatric disease and symptom relief, and this research has rapidly identified novel therapeutic targets for what could be a new generation of rational drug development. As these and related methodologies for controlling neurons ultimately make their way into the clinic, circuit-based strategies for alleviating psychiatric symptoms could become a remarkably refined approach to disease treatment. Keywords: optogenetics, depression, anxiety, addiction, obsessive-compulsive disorder
format article
author McDevitt RA
Reed SJ
Britt JP
author_facet McDevitt RA
Reed SJ
Britt JP
author_sort McDevitt RA
title Optogenetics in preclinical neuroscience and psychiatry research: recent insights and potential applications
title_short Optogenetics in preclinical neuroscience and psychiatry research: recent insights and potential applications
title_full Optogenetics in preclinical neuroscience and psychiatry research: recent insights and potential applications
title_fullStr Optogenetics in preclinical neuroscience and psychiatry research: recent insights and potential applications
title_full_unstemmed Optogenetics in preclinical neuroscience and psychiatry research: recent insights and potential applications
title_sort optogenetics in preclinical neuroscience and psychiatry research: recent insights and potential applications
publisher Dove Medical Press
publishDate 2014
url https://doaj.org/article/b833782657eb403e816d3049381d267a
work_keys_str_mv AT mcdevittra optogeneticsinpreclinicalneuroscienceandpsychiatryresearchrecentinsightsandpotentialapplications
AT reedsj optogeneticsinpreclinicalneuroscienceandpsychiatryresearchrecentinsightsandpotentialapplications
AT brittjp optogeneticsinpreclinicalneuroscienceandpsychiatryresearchrecentinsightsandpotentialapplications
_version_ 1718399537274421248